================================================================================
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
----------
FORM 8-K
----------
Current Report Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
Date of Report (date of earliest event reported): June 21, 1996
PhyMatrix Corp.
----------------------------------------------------
(Exact name of registrant as specified in its charter)
<TABLE>
<CAPTION>
Delaware 0-27568 65-0617076
- ------------------------------- ----------------------- --------------------------------
<S> <C> <C>
(State or other jurisdiction of (Commission File Number) (IRS Employer Identification No.)
incorporation)
</TABLE>
777 South Flagler Drive
West Palm Beach, FL 33401
--------------------------------------
(Address of principal executive offices)
(407) 655-3500
------------------------------
Registrant's telephone number,
including area code
===============================================================================
<PAGE>
Item 5. Other Events.
On June 21, 1996, the following press release was issued in connection
with PhyMatrix Corp.'s sale of convertible subordinated debentures:
"West Palm Beach, FL -- June 21, 1996 -- PhyMatrix Corporation (Nasdaq:
PHMX), a physician practice management company, today announced the
sale of $100 million principle amount of 6 3/4 percent convertible
subordinated debentures due 2003 to certain qualified institutional
investors, accredited investors, and non-U.S. persons. The debentures
will be convertible into PhyMatrix Corp. Common Stock. The closing is
scheduled for June 26, 1996.
The securities to be offered are not registered under the Securities
Act of 1933, as amended, or applicable state securities laws, and may
not be offered or sold absent registration under the Securities Act and
applicable state securities laws or available exemptions from
registrations."
* * *
<PAGE>
Signature
Pursuant to the requirements of the Securities Exchange Act of 1934,
the registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
PHYMATRIX CORP.
By: /s/ Frederick R. Leathers
-----------------------------
Frederick R. Leathers
Chief Financial Officer and
Treasurer
Dated: June 26, 1996
